1. Home
  2. NKTX vs GGT Comparison

NKTX vs GGT Comparison

Compare NKTX & GGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nkarta Inc.

NKTX

Nkarta Inc.

HOLD

Current Price

$2.66

Market Cap

198.2M

Sector

Health Care

ML Signal

HOLD

Logo Gabelli Multi-Media Trust Inc. (The)

GGT

Gabelli Multi-Media Trust Inc. (The)

HOLD

Current Price

$4.13

Market Cap

175.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
NKTX
GGT
Founded
2015
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
198.2M
175.2M
IPO Year
2020
1995

Fundamental Metrics

Financial Performance
Metric
NKTX
GGT
Price
$2.66
$4.13
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$11.33
N/A
AVG Volume (30 Days)
589.3K
285.3K
Earning Date
05-11-2026
01-01-0001
Dividend Yield
N/A
15.56%
EPS Growth
11.88
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$5.08
Revenue Growth
N/A
N/A
52 Week Low
$1.70
$3.87
52 Week High
$3.72
$4.39

Technical Indicators

Market Signals
Indicator
NKTX
GGT
Relative Strength Index (RSI) 60.57 51.46
Support Level $2.59 $4.15
Resistance Level $2.81 $4.25
Average True Range (ATR) 0.15 0.04
MACD 0.06 0.00
Stochastic Oscillator 98.37 40.63

Price Performance

Historical Comparison
NKTX
GGT

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK-cell expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

About GGT Gabelli Multi-Media Trust Inc. (The)

Gabelli Multimedia Trust Inc is a non-diversified closed-end management investment company. Its investment objective is the long-term growth of capital with income as a secondary objective. The fund invests majority of its assets, under normal market conditions, in common stock and other securities, including convertible securities, preferred stock, options, and warrants of companies in the telecommunications, media, publishing, and entertainment industries.

Share on Social Networks: